Emerson Electric (EMR) News Today

Emerson Electric Co. (NYSE: EMR) has recently moved higher, supported by a broad wave of analyst price-target increases. However, the stock’s reaction to strong quarterly results was initially muted, suggesting investors may already have priced in much of the company’s operational improvement.

• Positive Sentiment: Multiple analysts raised their targets: BMO Capital Markets increased its target to $175 from $157, Rothschild & Co. Redburn raised its target to $180 from $165, Stephens lifted its target to $160 from $155, and BNP Paribas Exane increased its target to $185 from $180. Citigroup also raised its target to $182, while RBC analysts indicated that the stock is expected to rise. MarketScreener BMO target article
• Positive Sentiment: Strong quarterly execution: Emerson reported fiscal third-quarter revenue of $4.873 billion, up 7%, with underlying sales and orders increasing 6% and 7%, respectively. Adjusted EPS rose to $1.71 from $1.52, exceeding the $1.68 consensus estimate, while adjusted segment EBITA margin expanded to 28.5%.
• Positive Sentiment: AI expansion: Emerson acquired Glue Inc., whose Glue Studio software uses AI to improve test generation and planning. The deal strengthens Emerson’s position in intelligent test and measurement software. Emerson acquires Glue Inc. article
• Neutral Sentiment: Guidance was raised, but modestly: Emerson increased fiscal 2026 adjusted EPS guidance to approximately $6.55 and free-cash-flow guidance to about $3.6 billion. Investors appear to be weighing the improved outlook against remaining tariff, geopolitical and integration risks.
• Negative Sentiment: Sell-the-news pressure and insider selling: Despite the earnings beat, the stock slipped as investors viewed the guidance increase as insufficiently strong relative to expectations. QuiverQuant also reported six insider sales and no insider purchases over the past six months, which may add a cautious signal.